This is pretty incredible, including warrants they are selling one third of the company. It has taken far too long to bring these tests to market.

insiders are expected to participate in the offering for an aggregate of approximately 20% of the offering.

They are saying revenues are inreasing

3M has taken receipt during the third quarter of RAMP(R) Readers and Flu test kits that are needed to prime the front-end of the flu distribution channel. We expect to ship against firm product orders from 3M throughout the next two quarters. As we approach the first quarter of 2009, current cumulative firm product orders and test development program funding from 3M and Roche is approximately $4.0 million. This and the net proceeds of the offering are expected to carry us through the first quarter of 2009

I am getting weary, but I think this company is going to make it, but the shareholders are going to die on the vine before there is other fruit.

~~ dimar